MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions
View by Date

Tuesday, September 24, 2019

1:45pm-3:15pm
No evidence for early emotional processing in the subthalamic nucleus – a single neuron study

T. Sieger, T. Serranová, F. Růžička, D. Urgošík, R. Jech (Prague, Czech Republic)

Neurophysiology  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Nocturnal stridor in multiple system atrophy: video-polysomnography and clinical features

H. Ryu, J. Paek, S. You, M. Kim, Y. Kim, J. Kim, K. Kim, S. Lee, S. Chung (Daegu, Republic of Korea)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Non-motor symptoms and risk of functional dependency in early Parkinson’s disease

R. Kim, D. Yoo, JH. Im, HJ. Kim, B. Jeon (Seoul, Republic of Korea)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Non-motor symptoms contribute to the caregiver burden in Progressive Supranuclear Palsy

ZC. Chen, YM. Liu (Jinan, China)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Non-motor symptoms in Myoclonus-Dystonia: a comparison to other dystonia subtypes

E. Timmers, M. Smit, A. Kuiper, A. Bartels, S. Vander Veen, A. Vander Stouwe, P. Santens, B. Bergmans, M. Tijssen (Groningen, Netherlands)

Dystonia  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Novel familial HPCA mutation associated with autosomal recessive dystonia: Strengthening the role of HPCA in hereditary movement disorders.

S. Siegert, W. Schmidt, R. Bittner, S. Gobara, M. Freilinger (Vienna, Austria)

Dystonia  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Nrf2 pathway in patients with Parkinson’s disease

T. Schirinzi, S. Petrillo, G. Di Lazzaro, N. Mercuri, E. Bertini, F. Piemonte, A. Pisani (Rome, Italy)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Nutritional status in patients with Parkinson’s disease and its relationship with the motor phenotype.

R. Cruz, J. Balderas, C. Navarro, L. Zuazua, M. Rodriguez, A. Cervantes (Mexico City, Mexico)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Objective assessment of motor states in Parkinson’s disease using partial least squares and smartphone data

M. Memedi, S. Aghanavesi (Borlänge, Sweden)

Rating Scales  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Objective evaluation criteria for diagnosis of spasmodic dysphonia

K. Kleim, K. Simonyan, T. Ball (Freiburg, Germany)

Dystonia  ·  Les Muses Terrace, Level 3
  • «Previous Page
  • 1
  • …
  • 43
  • 44
  • 45
  • 46
  • 47
  • …
  • 69
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
        • Help & Support
        • About Us
        • Cookies & Privacy
        • Wiley Job Network
        • Terms & Conditions
        • Advertisers & Agents
        Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
        Wiley